AstraZeneca is appealing against NICEs decision not to recommend funding for its lung cancer drug Tagrisso (osimertinib) in untreated patients with epidermal growth factor receptor (EGFR) mutations. In final draft guidance, NICE said it had rejected regular NHS funding for Tagrisso, because the survival benefits compared with standard treatment such as AZ’s older drug Iressa (gefitinib) are unclear in first-line non-small cell lung cancer. Tagrisso has been the driving force behind AZ&rsqu...
READ MORE
|
Machine learning a field of artificial intelligence that uses statistical techniques to enable computer systems to 'learn' from data can be used to analyze electronic health records and predict the risk of emergency hospital admissions, a new study from The George Institute for Global Health at the University of Oxford has found. The research, published in the journal PLOS Medicine, suggests that using these techniques could help health practitioners accurately monitor the risks faced by...
READ MORE
|
Guerbet (GBT) today announced the sale of its pharmaceutical site in Montreal (Canada) to MedXL, a specialist in medical devices and sterile pre-filled syringes.
The Montreal industrial facility specializes on the one hand in filling and finishing of contrast media and on the other in the large-series manufacture of syringes pre-filled with sterile solutions for third parties, which is not a core business for Guerbet. Guerbet will gradually transfer its contrast agent production, ...
GLOBENEWSWIRE
READ MORE
|
A global leader committed to innovating for a healthier world, today announced that it has joined Accenture’s open partner ecosystem, designed to help solution providers, software vendors and life sciences companies team more effectively to accelerate drug discovery and improve patient outcomes. The ecosystem is an integral part of Accenture’s cloud-based informatics research platform focused on improving productivity, efficiency and innovation in the drug discovery process. Accentur...
PERKINELMER, INC.
READ MORE
|
Researchers have combined commercially available hardware and open-source software, called PySight to improve rapid 2D and 3D brain imaging. They integrated the fastest 3D imaging solution with advances in microscopy aiding scientists to understand brain dynamics better and helping to discover new treatments.
The researchers describe PySight, a programme serving as an add-on for laser scanning microscopes. Utilising both software and hardware, the scientists improved the quality of 2D and...
READ MORE
|
Its becoming a familiar refrain- Women are making headway in the workplace. In 2019, more women are serving in Congress than ever before, and various industries the life sciences included are well into implementing programs to boost diversity. Hows pharma doing. By one measure, pretty well. The biggest pharma companies on the London Stock Exchange nearly tripled the number of women on their executive committees between 2018 and 2019. But that sort of progress didn't extend to all top job tit...
READ MORE
|